Treatment

Byooviz 10 mg/ml solution for injection clinical trials

1 indexed studies · 0 currently recruiting

Ongoing, recruitingTherapeutic exploratory (Phase II)
An open-label, single group, single-dose clinical study to evaluate the usability of the pre-filled syringe (PFS) of SB11 in trial participants with Neovascular Age-Related Macular Degeneration (AMD), Macular Oedema Secondary to Retinal Vein Occlusion (RVO), or Myopic Choroidal Neovascularization (mCNV)
This study is testing a new way to give eye medicine called Byooviz using a pre-filled syringe. It looks at how easy and safe this new method is for people with certain eye conditions that can cause sight loss.
For: Neovascular Age-Related Macular Degeneration (AMD) · Macular Oedema Secondary to Retinal Vein Occlusion (RVO) · Myopic Choroidal Neovascularization (mCNV)
Poland